Eleven Softwares logo
AI / MLHealthcare Research Organisation202512 weeks

Medical Research Chatbot

Evidence-backed answers for cancer patients, at the moment they need them most.

Healthcare Research Organisation

Case Study · 2025

Evidence-Backed Query ResponseClinical Trial MatchingLatest Research Study SurfacingSafety Layer & Out-of-Scope Handling24/7 Patient Availability

About this product

A generative AI-powered research chatbot built specifically for breast cancer patients — delivering real-time, evidence-backed answers to clinical queries, surfacing the latest studies and clinical trials, and serving as a personal research assistant available 24 hours a day.

Timeline

12 weeks

Category

AI / ML

Delivered

2025

Stack

PythonFastAPILangChainOpenAI GPT-4oRAG (Retrieval-Augmented Generation)Pinecone (Vector DB)PubMed APIClinicalTrials.gov APIPostgreSQLAWSReact.jsFigma

Product Preview

Medical Research Chatbot preview

Why it works

Measurable impact, by design

Faster Query Response

vs. waiting for clinical team availability

100%

Source-Cited Outputs

RAG architecture — no hallucination

24/7

Always-On Research Access

evidence-backed answers at any hour

500+

Queries Accuracy Validated

oncologist-reviewed benchmark before launch

Overview

The situation

Breast cancer patients navigating their diagnosis face an overwhelming volume of medical information — clinical studies, trial eligibility, treatment protocols, drug interactions, and research updates — with no reliable way to access it quickly, understand it accurately, or apply it to their specific situation. They were turning to generic search engines, getting unreliable results, and waiting days for responses from overloaded clinical teams. We built a medical research chatbot that changed this dynamic entirely: a personal AI research assistant grounded in reputable medical sources, capable of answering evidence-backed clinical questions in real time and surfacing the latest studies and clinical trials relevant to each patient's situation.

Challenge

What we had to solve

Medical AI chatbots operate in a zero-tolerance accuracy environment — a hallucinated drug interaction or an incorrectly summarised clinical trial isn't a product bug, it's a patient safety risk. The system had to be grounded exclusively in verified, reputable medical literature and never generate responses beyond the boundaries of its knowledge base. Beyond accuracy, the challenge was accessibility: the system needed to translate dense clinical language into responses a patient without a medical degree could understand and act on, without losing the precision that made the information medically useful. Every response had to be both trustworthy and genuinely helpful.

What it does

Core capabilities

01Capability 01

Evidence-Backed Query Response

Every response the chatbot generates is grounded in a curated knowledge base of verified medical literature — clinical guidelines, peer-reviewed oncology studies, and authoritative drug databases — using a RAG architecture that prevents hallucination at the system level. Patients receive accurate, cited answers to clinical questions in plain English, with the medical precision of a research summary and the accessibility of a conversation. The system never generates responses beyond the boundaries of its verified knowledge base, and every answer includes source attribution so patients can share retrieved information directly with their care team.

02Capability 02

Clinical Trial Matching

Patients describe their diagnosis, staging, prior treatments, and eligibility criteria in natural language — and the chatbot returns a structured summary of potentially relevant open clinical trials, filtered and ranked by relevance. Trial summaries include plain-language explanations of eligibility requirements, trial phase, treatment arm, and enrolment status — giving patients actionable information they can bring to their oncologist rather than raw registry data they can't interpret. The module connects to live trial registry feeds, ensuring results reflect currently open studies rather than outdated entries.

03Capability 03

Latest Research Study Surfacing

The chatbot retrieves and summarises the most recent published research relevant to a patient's specific query — presenting key findings, study design, sample size, and clinical significance in plain language. Patients who previously had no reliable way to understand the research landscape for their diagnosis can now ask natural-language questions and receive structured research summaries in seconds. Every study summary is accompanied by a citation and a link to the source, giving patients and their clinical teams a direct path to the full paper.

04Capability 04

Safety Layer & Out-of-Scope Handling

Medical AI in a patient-facing context requires explicit boundaries that are enforced at the system level, not the prompt level. The chatbot's safety layer detects queries outside its knowledge scope — treatment recommendations, dosage decisions, or diagnosis confirmation — and responds with a graceful redirect to appropriate clinical resources rather than an attempted answer. Response generation is calibrated to present information with appropriate clinical humility, always framing outputs as research assistance rather than medical advice. Continuous monitoring flags low-confidence responses for clinical review, maintaining a human oversight layer throughout the system's operation.

Outcomes

Patients with faster answers, better informed conversations, and stronger clinical partnerships.

24/7

Research access for patients

evidence-backed answers at any hour, instantly

Faster query response time

vs. waiting for clinical team availability

100%

Grounded, source-cited responses

RAG architecture eliminated hallucination

500+

Query benchmark accuracy validated

oncologist-reviewed before launch

2

Live data integrations

PubMed and ClinicalTrials.gov — always current

12wks

Delivered on schedule

discovery to production-ready medical AI chatbot

"

Our patients were spending hours searching for reliable information and still arriving at consultations with more anxiety than answers. The chatbot changed that — they come in with their questions already partially answered and their relevant trials already identified. It has genuinely improved the quality of our clinical conversations.

HR

Healthcare Research Organisation

Client, Oncology Research

Want results like these?

Let's talk about what we can build together.